Molecular testing for BRAF V600 mutations in the BRIM-2 trial of the BRAF inhibitor vemurafenib in metastatic melanoma.
K. J. Bloom
Employment or Leadership Position - Clarient
S. M. Anderson
Employment or Leadership Position - LabCorp
Stock Ownership - LabCorp
R. C. Schilling
Employment or Leadership Position - Roche
J. R. Lee
Consultant or Advisory Role - Roche
H. Halait
Employment or Leadership Position - Roche
S. Cheng
Employment or Leadership Position - Roche
Stock Ownership - Roche
R. A. Langland
Employment or Leadership Position - Roche
H. J. Lawrence
Employment or Leadership Position - Roche